Immune surveillance and immunotherapy: Lessons from carbohydrate mimotopesPASHOV, Anastas; MONZAVI-KARBASSI, Behjatolah; KIEBER-EMMONS, Thomas et al.Vaccine. 2009, Vol 27, Num 25-26, pp 3405-3415, issn 0264-410X, 11 p.Conference Paper

Virus-based immunotherapy of cancer: what do we know and where are we going? : Review articleSORENSEN, Maria Rathmann; THOMSEN, Allan Randrup.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2007, Vol 115, Num 11, pp 1177-1193, issn 0903-4641, 17 p.Article

Targeted microbeads for attraction and induction of specific innate immune response in the tumor microenvironmentSHAHAR, Ehud; GORODETSKY, Raphael; GABERMAN, Elena et al.Vaccine. 2010, Vol 28, Num 45, pp 7279-7287, issn 0264-410X, 9 p.Article

Replicative senescence of CD8 T cells: potential effects on cancer immune surveillance and immunotherapyEFFROS, Rita B.Cancer immunology and immunotherapy. 2004, Vol 53, Num 10, pp 925-933, issn 0340-7004, 9 p.Article

Effectiveness of slow-release systems in CD40 agonistic antibody immunotherapy of cancerFRANSEN, Marieke F; CORDFUNKE, Robert A; SLUIJTER, Marjolein et al.Vaccine. 2014, Vol 32, Num 15, pp 1654-1660, issn 0264-410X, 7 p.Article

Preparation and anti-tumor evaluation of polyactin A microparticles from supercritical CO₂ processingJIANHONG BI; JINGLAN ZHAO; LANG BAO et al.Applied surface science. 2008, Vol 255, Num 2, pp 320-323, issn 0169-4332, 4 p.Conference Paper

Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapyZHEN HUANG; ZHENGPING ZHANG; YUCUI JIANG et al.Journal of controlled release. 2012, Vol 158, Num 2, pp 286-292, issn 0168-3659, 7 p.Article

Noninvasive and efficient transdermal delivery of CpG-oligodeoxynucleotide for cancer immunotherapyKIGASAWA, Kaoru; KAJIMOTO, Kazuaki; NAKAMURA, Takashi et al.Journal of controlled release. 2011, Vol 150, Num 3, pp 256-265, issn 0168-3659, 10 p.Article

MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitroRAY, Swagatam; CHHABRA, Arvind; ECONOMOU, James S et al.Clinical immunology (Orlando, Fla. Print). 2010, Vol 136, Num 3, pp 338-347, issn 1521-6616, 10 p.Article

Neuroimmunomodulation in Medical Oncology : Application of Psychoneuroimmunology with Subcutaneous Low-dose IL-2 and the Pineal Hormone Melatonin in Patients with Untreatable Metastatic Solid TumorsLISSONI, Paolo; BRIVIO, Fernando; FUMAGALLI, Luca et al.Anticancer research. 2008, Vol 28, Num 2B, pp 1377-1381, issn 0250-7005, 5 p.Article

Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cellQIANLI WANG; JUNPING ZHANG; ZHONGWU GUO et al.Bioorganic & medicinal chemistry. 2007, Vol 15, Num 24, pp 7561-7567, issn 0968-0896, 7 p.Article

Adoptive transfer of Epstein-Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomasCHO, Hyun-Il; YOUNG SEON HONG; MYUNG AH LEE et al.International journal of hematology. 2006, Vol 83, Num 1, pp 66-73, issn 0925-5710, 8 p.Article

Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant : therapeutic activity against human cervical cancer in a rodent modelZHENGRONG CUI; FU QIU.Cancer immunology and immunotherapy. 2006, Vol 55, Num 10, pp 1267-1279, issn 0340-7004, 13 p.Article

Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulinILSIEH, Chia-Jung; TAE WOO KIM; HUNG, Chien-Fu et al.Vaccine. 2004, Vol 22, Num 29-30, pp 3993-4001, issn 0264-410X, 9 p.Article

Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residuesTSUBOI, Akihiro; OKA, Yoshihiro; KAWAKAMI, Manabu et al.Cancer immunology and immunotherapy. 2002, Vol 51, Num 11-12, pp 614-620, issn 0340-7004, 7 p.Article

Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2CSNOOK, Adam E; MAGEE, Michael S; MARSZALOWICZ, Glen P et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 5, pp 713-723, issn 0340-7004, 11 p.Article

IRX-2, a novel biologic, favors the expansion of T effector over T regulatory cells in a human tumor microenvironment modelSCHILLING, Bastian; HARASYMCZUK, Malgorzata; SCHULER, Patrick et al.Journal of molecular medicine (Berlin. Print). 2012, Vol 90, Num 2, pp 139-147, issn 0946-2716, 9 p.Article

Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapyLEI QIU; XI GONG; QIANLI WANG et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 11, pp 2045-2054, issn 0340-7004, 10 p.Article

Prophylactic immunization with Bubble liposomes and ultrasound-treated dendritic cells provided a four-fold decrease in the frequency of melanoma lung metastasisODA, Yusuke; SUZUKI, Ryo; MARUYAMA, Kazuo et al.Journal of controlled release. 2012, Vol 160, Num 2, pp 362-366, issn 0168-3659, 5 p.Article

The preclinical and clinical activity of aviscumine: A potential anticancer drugZWIERZINA, Heinz; BERGMANN, Lothar; FIEBIG, Heiner et al.European journal of cancer (1990). 2011, Vol 47, Num 10, pp 1450-1457, issn 0959-8049, 8 p.Article

HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapyZIZZARI, Ilaria Grazia; VEGLIA, Filippo; BENEDETTI-PANICI, Pierluigi et al.Journal of molecular medicine (Berlin. Print). 2011, Vol 89, Num 12, pp 1231-1240, issn 0946-2716, 10 p.Article

FOCUS on FOCIS : Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancerROGKOVA, Daniela; TISEROVA, Hana; SEDIVA, Anna et al.Clinical immunology (Orlando, Fla. Print). 2009, Vol 131, Num 1, pp 1-10, issn 1521-6616, 10 p.Article

Identification and modification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from Ran antigenFAN LI; DI YANG; YIQIN WANG et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 12, pp 2039-2049, issn 0340-7004, 11 p.Article

Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cellsSCHUURHUIS, Danita H; LESTERHUIS, W. Joost; PUNT, Cornelis J. A et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 7, pp 1109-1115, issn 0340-7004, 7 p.Article

Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanomaTOOMEY, Deirdre; CONROY, Helen; JARNICKI, Andrew G et al.Vaccine. 2008, Vol 26, Num 27-28, pp 3540-3549, issn 0264-410X, 10 p.Article